Victory Capital Management Inc Ascendis Pharma A/S Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Victory Capital Management Inc holds 133,858 shares of ASND stock, worth $18.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

133,858

Previous 134,409 0.41%

Holding current value

$18.2 Million

Previous $18.3 Million 9.06%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$113.0 - $153.43 $62,263 - $84,539	-551 Reduced 0.41%	133,858 $20 Million
Q2 2024 Aug 05, 2024	SELL	$121.07 - $153.67 $18,765 - $23,818	-155 Reduced 0.12%	134,409 $18.3 Million
Q1 2024 May 03, 2024	BUY	$123.45 - $159.4 $16.6 Million - $21.4 Million	134,564 New	134,564 $20.3 Million
Q2 2021 Aug 03, 2021	SELL	$121.62 - $145.29 $63 Million - $75.3 Million	-518,396 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$124.92 - $173.33 $1.33 Million - $1.84 Million	10,638 Added 2.1%	518,396 $66.8 Million
Q4 2020 Feb 01, 2021	BUY	$151.2 - $182.76 $21.5 Million - $26 Million	142,341 Added 38.95%	507,758 $84.7 Million
Q3 2020 Nov 09, 2020	SELL	$134.29 - $154.32 $4.43 Million - $5.1 Million	-33,021 Reduced 8.29%	365,417 $56.4 Million
Q2 2020 Aug 07, 2020	SELL	$110.87 - $156.01 $342,366 - $481,758	-3,088 Reduced 0.77%	398,438 $58.9 Million
Q1 2020 May 04, 2020	SELL	$97.01 - $145.11 $13.9 Million - $20.8 Million	-143,439 Reduced 26.32%	401,526 $45.2 Million
Q4 2019 Feb 06, 2020	SELL	$91.45 - $139.12 $277,093 - $421,533	-3,030 Reduced 0.55%	544,965 $75.8 Million
Q4 2019 Feb 04, 2020	BUY	$91.45 - $139.12 $10 Million - $15.2 Million	109,481 Added 24.97%	547,995 $74 Million
Q3 2019 Nov 12, 2019	BUY	$95.8 - $118.9 $9.35 Million - $11.6 Million	97,606 Added 28.63%	438,514 $42.2 Million
Q2 2019 Aug 15, 2019	BUY	$107.11 - $132.09 $1.95 Million - $2.4 Million	18,190 Added 5.64%	340,908 $39.3 Million
Q1 2019 May 03, 2019	BUY	$62.15 - $129.99 $18.6 Million - $38.9 Million	299,400 Added 1283.99%	322,718 $38 Million
Q4 2018 Feb 05, 2019	SELL	$55.16 - $69.67 $23,167 - $29,261	-420 Reduced 1.77%	23,318 $1.46 Million
Q3 2018 Nov 01, 2018	SELL	$63.77 - $76.28 $79,074 - $94,587	-1,240 Reduced 4.96%	23,738 $1.68 Million
Q2 2018 Aug 02, 2018	SELL	$58.55 - $73.92 $79,628 - $100,531	-1,360 Reduced 5.16%	24,978 $1.66 Million
Q1 2018 May 04, 2018	BUY	$38.98 - $68.04 $349,650 - $610,318	8,970 Added 51.65%	26,338 $1.72 Million
Q4 2017 Feb 01, 2018	BUY	$31.98 - $40.38 $384,079 - $484,963	12,010 Added 224.15%	17,368 $696,000
Q3 2017 Oct 27, 2017	BUY	$26.89 - $37.1 $144,076 - $198,781	5,358	5,358 $194,000

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.57B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Ascendis Pharma A/S Transaction History